keyword
Keywords cyclophosphamide pharmaceutic ...

cyclophosphamide pharmaceutic - tecnology

https://read.qxmd.com/read/38044431/induction-of-cyp3a-activity-by-dexamethasone-may-not-be-strong-even-at-high-doses-insights-from-a-case-of-tacrolimus-co-administration
#21
JOURNAL ARTICLE
Yoshiyuki Ohno, Toyohito Oriyama, Akira Honda, Mineo Kurokawa, Tappei Takada
BACKGROUND: Dexamethasone (DEX) induces CYP3A activity in a concentration-dependent manner. However, no study has examined changes in the blood concentration of CYP3A substrate drugs when DEX is administered at high doses. Herein, we present a case in which tacrolimus (TAC), a typical CYP3A substrate drug, was co-administered with a chemotherapy regimen that included high-dose DEX. CASE PRESENTATION: A 71-year-old woman underwent liver transplantation for hepatocellular carcinoma 18 years prior to her inclusion in this case study...
December 4, 2023: Journal of Pharmaceutical Health Care and Sciences
https://read.qxmd.com/read/38039010/circulating-micrornas-as-novel-biomarkers-for-measuring-the-potency-of-ginger-extract-against-cyclophosphamide-toxicity-in-rat-renal-tissues-molecular-and-histopathological-study
#22
JOURNAL ARTICLE
S A Gabr, W M Elsaed, M A Eladl, G A Ghoniem, M El-Sherbiny, K S El-Bayoumi, H Abouhish, A M Desouky, M M Abdel-Aziz, M Eldesoqui, M Elshafey, H A Ebrahim, N S Nosseir, A M R El-Sayed
OBJECTIVE: This study aims to explore underlying molecular variations in the expression of miRNAs in kidney tissues of ginger-treated and non-treated cyclophosphamide (CP)-intoxicated rats. MATERIALS AND METHODS:   A total of 40 adult male Wistar rats were randomly divided into four groups of 10 each: Group I (control: received normal food and water), Group II (received ginger at a dose of 300 mg/kg), Group III (received CP 75 mg/kg, i.p.), and Group IV (received the same dose of CP and ginger extract)...
November 2023: European Review for Medical and Pharmacological Sciences
https://read.qxmd.com/read/38008966/the-protective-effect-of-taurine-on-cyclophosphamide-induced-testicular-toxicity-in-rats
#23
JOURNAL ARTICLE
Muhammed Cemil Busı, Semra Yigitaslan, Zuhal Kaltus, Nusin Harmancı, Ezgi Eroglu, Orhan Ozatık, Coskun Kaya
This study aimed to evaluate the protective effect of taurine (TAU) with regard to antioxidant, anti inflammatory and antiapoptotic pathways on cyclophosphamide (CP)-induced testicular toxicity in rats. Forty Sprague-Dawley male rats were used in this experimental study. The CP group animals received a single dose of 200mg/kg CP on Day 8 intraperitoneally (i.p). The other groups were treated with TAU (75, 150 and 300mg/kg) orally for 14 days prior to and following a single i.p injection of CP. Morphometrical analysis and histological examination of testicular tissue were performed...
September 2023: Pakistan Journal of Pharmaceutical Sciences
https://read.qxmd.com/read/37973299/hazard-assessment-of-antineoplastic-drugs-and-metabolites-using-cytotoxicity-and-genotoxicity-assays
#24
JOURNAL ARTICLE
Mariana de Oliveira Klein, Luiza Flavia Veiga Francisco, Izabela Natália Faria Gomes, Sergio V Serrano, Rui M Reis, Henrique C S Silveira
Antineoplastic drugs are among the most toxic pharmaceuticals. Their release into the aquatic ecosystems has been reported, giving rise to concerns about the adverse effects, including cytotoxicity and genotoxicity, that they may have on exposed organisms. In this study, we analyzed the cytotoxicity and genotoxicity of 5-fluorouracil (5-FU) and its metabolite alpha-fluoro-beta-alanine (3-NH2-F); gemcitabine (GEM) and its metabolite 2'-deoxy-2',2'-difluorouridine (2-DOH-DiF); as well as cyclophosphamide (CP) on the HepG2 cell line...
2023: Mutation Research. Genetic Toxicology and Environmental Mutagenesis
https://read.qxmd.com/read/37899177/quantitative-31-p-nmr-for-the-purity-determination-of-the-organophosphorus-compound-brigatinib-and-its-method-validation
#25
JOURNAL ARTICLE
Nahoko Uchiyama, Junko Hosoe, Takanori Komatsu, Naoki Sugimoto, Kyoko Ishizuki, Tatsuo Koide, Mika Murabayashi, Taeko Shinozaki, Kengo Kobayashi, Yoshinori Fujimine, Katsuya Ofuji, Hitoshi Shimizu, Takashi Hasebe, Yumi Asai, Eri Ena, Kohei Kiyota, Kazuhiro Fujita, Yoshinobu Makino, Toru Miura, Yasuhiro Muto, Katsuo Asakura, Takako Suematsu, Hitomi Muto, Ai Kohama, Takashi Goto, Masu Yasuda, Tomohiko Ueda, Yukihiro Goda
The spectrum of 31 P-NMR is fundamentally simpler than that of 1 H-NMR; consequently identifying the target signal(s) for quantitation is simpler using quantitative 31 P-NMR (31 P-qNMR) than using quantitative 1 H-NMR (1 H-qNMR), which has been already established as an absolute determination method. We have previously reported a 31 P-qNMR method for the absolute determination of cyclophosphamide hydrate and sofosbuvir as water-soluble and water-insoluble organophosphorus compounds, respectively. This study introduces the purity determination of brigatinib (BR), an organophosphorus compound with limited water solubility, using 31 P-qNMR at multiple laboratories...
October 27, 2023: Chemical & Pharmaceutical Bulletin
https://read.qxmd.com/read/37895893/complementarity-between-microbiome-and-immunity-may-account-for-the-potentiating-effect-of-quercetin-on-the-antitumor-action-of-cyclophosphamide-in-a-triple-negative-breast-cancer-model
#26
JOURNAL ARTICLE
Andrea Manni, Yuan-Wan Sun, Todd D Schell, Tymofiy Lutsiv, Henry Thompson, Kun-Ming Chen, Cesar Aliaga, Junjia Zhu, Karam El-Bayoumy
Immunotherapy targeting program cell death protein 1 (PD-1) in addition to chemotherapy has improved the survival of triple-negative breast cancer (TNBC) patients. However, the development of resistance and toxicity remain significant problems. Using the translationally relevant 4T1 mouse model of TNBC, we report here that dietary administration of the phytochemical quercetin enhanced the antitumor action of Cyclophosphamide, a cytotoxic drug with significant immunogenic effects that is part of the combination chemotherapy used in TNBC...
October 6, 2023: Pharmaceuticals
https://read.qxmd.com/read/37888466/fish-collagen-peptides-enhance-thymopoietic-gene-expression-cell-proliferation-thymocyte-adherence-and-cytoprotection-in-thymic-epithelial-cells-via-activation-of-the-nuclear-factor-%C3%AE%C2%BAb-pathway-leading-to-thymus-regeneration-after-cyclophosphamide-induced-injury
#27
JOURNAL ARTICLE
Do Young Lee, Won Hoon Song, Ye Seon Lim, Changyong Lee, Lata Rajbongshi, Seon Yeong Hwang, Byoung Soo Kim, Dongjun Lee, Yong Jung Song, Hwi-Gon Kim, Sik Yoon
Prolonged thymic involution results in decreased thymopoiesis and thymic output, leading to peripheral T-cell deficiency. Since the thymic-dependent pathway is the only means of generating fully mature T cells, the identification of strategies to enhance thymic regeneration is crucial in developing therapeutic interventions to revert immune suppression in immunocompromised patients. The present study clearly shows that fish collagen peptides (FCPs) stimulate activities of thymic epithelial cells (TECs), including cell proliferation, thymocyte adhesion, and the gene expression of thymopoietic factors such as FGF-7, IGF-1, BMP-4, VEGF-A, IL-7, IL-21, RANKL, LTβ, IL-22R, RANK, LTβR, SDF-1, CCL21, CCL25, CXCL5, Dll1, Dll4, Wnt4, CD40, CD80, CD86, ICAM-1, VCAM-1, FoxN1, leptin, cathepsin L, CK5, and CK8 through the NF-κB signal transduction pathway...
October 12, 2023: Marine Drugs
https://read.qxmd.com/read/37817526/ginger-s-antiapoptotic-and-antioxidant-effects-on-ovaries-of-cyclophosphamide-therapied-rats
#28
JOURNAL ARTICLE
Maryamsadat Shahidi, Omid Abazari, Parisa Dayati, Bibi Fatemeh Haghirosadat, Fatemeh Oroojalian, Javad Zavar Reza, Seyed Morteza Naghib
BACKGROUND: In the recent decade, there has been increasing interest in preventing ovarian toxicity after chemotherapy exposure. It has been documented that ginger (Zingiber officinale) might normalize the hormonal balance and control the menstrual cycle. OBJECTIVE: This study has analyzed whether ginger extract protects against cyclophosphamide (CP)-induced ovarian failure in rats. METHODS: Rats were distributed into four groups consisting of vehicle, CP, ginger, and CP + ginger...
October 4, 2023: Current Pharmaceutical Design
https://read.qxmd.com/read/37802816/-qirong-tablets-inhibits-apoptosis-of-ovarian-granulosa-cells-via-pi3k-akt-hif-1-signaling-pathway
#29
JOURNAL ARTICLE
Nan Nan, Xiao-Li DU, Miao Chen, Jia-Qi Luo
This study aims to observe the effect and explore the mechanism of Qirong Tablets in the treatment of premature ovarian insufficiency(POI) in mice via the phosphatidylinositol 3-kinase(PI3K)/protein kinase B(Akt)/hypoxia inducible factor 1(HIF-1) signaling pathway. Sixty SPF female BALB/c mice were randomly divided into normal group, model group, positive control group, Qirong Tablets low-, medium-and high-dose group. The normal group was intraperitoneally injected with the same amount of normal saline, and the other groups were intraperitoneally injected with cyclophosphamide 120 mg·kg~(-1)·d~(-1) once to establish a POI animal model...
September 2023: Zhongguo Zhong Yao za Zhi, Zhongguo Zhongyao Zazhi, China Journal of Chinese Materia Medica
https://read.qxmd.com/read/37783101/design-synthesis-and-biological-evaluation-of-novel-2-4-thiazolidinedione-derivatives-able-to-target-the-human-bag3-protein
#30
JOURNAL ARTICLE
Federica Budassi, Chiara Marchioro, Martina Canton, Annagiulia Favaro, Mattia Sturlese, Chiara Urbinati, Marco Rusnati, Romeo Romagnoli, Giampietro Viola, Elena Mariotto
The Bcl-2-associated athanogene 3 (BAG3) protein plays multiple roles in controlling cellular homeostasis, and it has been reported to be deregulated in many cancers, leading tumor cell apoptosis escape. BAG3 protein is then an emerging target for its oncogenic activities in both leukemia and solid cancers, such as medulloblastoma. In this work a series of forty-four compounds were designed and successfully synthesized by the modification and optimization of a previously reported 2,4-thiazolidinedione derivative 28...
September 22, 2023: European Journal of Medicinal Chemistry
https://read.qxmd.com/read/37776872/minimal-residual-disease-response-adapted-therapy-in-newly-diagnosed-multiple-myeloma-master-final-report-of-the-multicentre-single-arm-phase-2-trial
#31
MULTICENTER STUDY
Luciano J Costa, Saurabh Chhabra, Eva Medvedova, Bhagirathbhai R Dholaria, Timothy M Schmidt, Kelly N Godby, Rebecca Silbermann, Binod Dhakal, Susan Bal, Smith Giri, Anita D'Souza, Aric C Hall, Pamela Hardwick, James Omel, Robert F Cornell, Parameswaran Hari, Natalie S Callander
BACKGROUND: For patients with newly diagnosed multiple myeloma, reaching minimal residual disease (MRD) negativity after treatment is associated with improved outcomes; however, the use of MRD to modulate therapy remains elusive. We present the final analysis of the MASTER trial of daratumumab, carfilzomib, lenalidomide, and dexamethasone (Dara-KRd) therapy in patients with newly diagnosed multiple myeloma, in which MRD status is used to modulate treatment duration and cessation. METHODS: MASTER was a multicentre, single-arm, phase 2 trial conducted in five academic medical centres in the USA...
November 2023: Lancet Haematology
https://read.qxmd.com/read/37775330/-activation-of-cyp3a-by-abc-phenomenon-potentiates-the-hepatocellular-carcinoma-targeting-therapeutic-effects-of-pegylated-anticancer-prodrug-liposomes
#32
JOURNAL ARTICLE
Xue Zhang, Jianquan Pan, Xi Ye, Yunna Chen, Lei Wang, Xiangyun Meng, Weidong Chen, Fengling Wang
Reduced enzyme activity in hepatocellular carcinoma (HCC) and poor targeting limit the application of enzyme-activating prodrugs, which is also detrimental to the effective treatment of HCC. Here, we investigated whether accelerated blood clearance (ABC) phenomenon occurs in HCC models following repeated injections of PEGylated liposomes (PEG-L), thus inducing prodrugs accumulation and activation in the liver and exerting highly effective and low-toxicity therapeutic effects on HCC. Firstly, PEGylated liposomal cyclophosphamide (PEG-CP-L) was prepared by solvent injection and characterized...
September 29, 2023: Drug Metabolism and Disposition: the Biological Fate of Chemicals
https://read.qxmd.com/read/37765120/the-impact-of-metformin-on-the-development-of-hypothyroidism-and-cardiotoxicity-induced-by-cyclophosphamide-methotrexate-and-fluorouracil-in-rats
#33
JOURNAL ARTICLE
Ahmad H Alhowail, Maha A Aldubayan
Cyclophosphamide (CYP), methotrexate (MTX), and 5-fluorouracil (5-FU) are extensively utilized in the therapeutic management of various malignancies. It is noteworthy, however, that potential chemotherapy-related complications include the occurrence of hypothyroidism and cardiotoxicity. Metformin (MET) is a pharmacological agent for managing type 2 diabetes. It has been reported to mitigate certain toxic manifestations associated with chemotherapy. This study's primary objective is to investigate MET's protective effects against hypothyroidism and cardiotoxicity induced by CMF treatment...
September 16, 2023: Pharmaceuticals
https://read.qxmd.com/read/37736166/chitosan-coated-mil-100-fe-as-an-anticancer-drug-carrier-theoretical-and-experimental-investigation
#34
JOURNAL ARTICLE
Shabnam Tohidi, Mehrdad Aghaie-Khafri
MIL-100(Fe) was synthesized under biofriendly conditions at room temperature and pressure using iron(II) chloride as the source of iron, and it was coated with chitosan (CS), a natural polysaccharide. In this study, we used a computational technique to predict the amount of drug loading in MIL-100(Fe) and MIL-100(Fe)/CS with molecular dynamics software LAMMPS. Powder X-ray diffraction analysis was conducted to characterize the chitosan-coated MIL-100(Fe) loaded with cyclophosphamide (MIL-100(Fe)/CS/CP). The drug loading and release processes were quantified using UV spectroscopy at 193 nm...
September 14, 2023: ACS Medicinal Chemistry Letters
https://read.qxmd.com/read/37702406/comparison-of-statistical-methods-for-extrapolating-survival-in-previously-untreated-diffuse-large-b-cell-lymphoma-results-based-on-the-polarix-study
#35
JOURNAL ARTICLE
Rodrigo S Ho, Aino Launonen
OBJECTIVE: The ongoing Phase III randomized POLARIX study (GO39942; NCT03274492) demonstrated significantly improved progression-free survival (PFS) with polatuzumab vedotin plus rituximab, cyclophosphamide, doxorubicin and prednisone (Pola-R-CHP) versus rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in patients with previously untreated diffuse large B-cell lymphoma (DLBCL). We compared statistical methodologies to extrapolate long-term PFS data from POLARIX...
2023: Journal of Medical Economics
https://read.qxmd.com/read/37674384/us-cost-effectiveness-analysis-of-polatuzumab-vedotin-in-previously-untreated-diffuse-large-b-cell-lymphoma
#36
JOURNAL ARTICLE
Matthew Matasar, Anthony Masaquel, Rodrigo S Ho, Aino Launonen, Carmen D Ng, Rongrong Wang, David Fox, Farah Hossain, Jia Li, John M Burke
AIMS: We evaluated the pharmacoeconomic value of polatuzumab vedotin plus rituximab, cyclophosphamide, doxorubicin, and prednisone (Pola-R-CHP) in previously untreated diffuse large B-cell lymphoma (DLBCL) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP). MATERIALS AND METHODS: A 3-state partitioned survival model was used to estimate life years (LYs), quality-adjusted LYs (QALYs), and cost impacts of Pola-R-CHP versus R-CHOP...
2023: Journal of Medical Economics
https://read.qxmd.com/read/37656225/cost-effectiveness-of-combination-therapy-of-polatuzumab-vedotin-plus-rituximab-cyclophosphamide-doxorubicin-and-prednisolone-for-previously-untreated-diffuse-large-b-cell-lymphoma-in-japan
#37
JOURNAL ARTICLE
Takashi Mizuoka, Hiroyuki Sakamaki, Shigeo Fuji, Shota Saito, Tatsunori Murata, Shinya Ohno, Naoki Inubashiri, Tomoha Oshima, Kazuhito Yamamoto
AIM: The POLARIX trial showed that Pola + R-CHP (polatuzumab vedotin plus rituximab, cyclophosphamide, doxorubicin, and prednisolone) prolongs progression-free survival (PFS) in patients with previously untreated diffuse large B-cell lymphoma (DLBCL) compared with R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone), the conventional standard of care, with a similar safety profile. However, Pola + R-CHP has not been evaluated from the viewpoint of health economics in Japan...
2023: Journal of Medical Economics
https://read.qxmd.com/read/37647098/human-serum-albumin-nanoparticles-as-a-carrier-of-20-s-protopanaxadiol-via-intramuscular-injection-to-alleviate-cyclophosphamide-induced-myelosuppression
#38
JOURNAL ARTICLE
Lei Liu, Bing Yang, Haoyang Yuan, Nini Yu, Yupeng Feng, Yu Zhang, Tian Yin, Haibing He, Jingxin Gou, Xing Tang
Myelosuppression is a prevalent and potentially life-threatening side effect during chemotherapy. As the main active component of ginseng, 20( S )-protopanaxadiol (PPD) is capable of relieving myelosuppression by restoring hematopoiesis and immunity. In this study, PPD was encapsulated in human albumin nanoparticles (PPD-HSA NPs) by nanoparticle albumin-bound (Nab) technology for intramuscular injection to optimize its pharmacokinetic properties and promote recovery of myelosuppression. The prepared PPD-HSA NPs had a particle size of about 280 nm with a narrow size distribution...
August 30, 2023: Molecular Pharmaceutics
https://read.qxmd.com/read/37631067/development-and-validation-of-a-novel-uhplc-ms-ms-method-for-the-quantification-of-plinabulin-in-plasma-and-its-application-in-a-pharmacokinetic-study-with-leukopenic-rats
#39
JOURNAL ARTICLE
Xiaochen Niu, Dan Chen, Wei He, Yu Tang, Jianchun Zhao
Plinabulin, a new antitumor drug developed from marine natural products that targets microtubules in cancer cells, is currently being tested in a phase III clinical study. Plinabulin has been clinically proven to be effective on leukopenia. However, to our knowledge, there are no reports investigating the pharmacokinetics of plinabulin in individuals with leukopenia and healthy individuals. In this study, we developed a rapid and sensitive UHPLC-MS/MS method for the detection of plinabulin for the first time...
August 14, 2023: Pharmaceuticals
https://read.qxmd.com/read/37619680/immunomodulatory-mechanisms-of-an-acidic-polysaccharide-from-the-fermented-burdock-residue-by-rhizopus-nigricans-in-raw264-7-cells-and-cyclophosphamide-induced-immunosuppressive-mice
#40
JOURNAL ARTICLE
Xuan Xu, Taili Shao, Ying Meng, Chunyan Liu, Pengying Zhang, Kaoshan Chen
RBAPS is an acidic polysaccharide extracted from the burdock residue fermentation by Rhizopus nigricans. In RBAPS-activated RAW264.7 cells, transcriptome analysis identified a total of 1520 differentially expressed genes (DEGs), including 1223 down-regulated genes and 297 up-regulated genes. DEGs were enriched in the immune-related biological processes, involving in Mitogen-activated protein kinase (MAPK) and Toll-like receptor (TLR) signaling pathway, according to Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis...
August 22, 2023: International Journal of Biological Macromolecules
keyword
keyword
109910
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.